Medical/Pharmaceuticals
Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
WOBURN, Mass., March 14, 2025 /PRNewswire/ -- Azurity Pharmaceuticals ("Azurity") announced today the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of Azurity. This strategic ...
2025-03-14 20:52
2874
China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease
SAN FRANCISCO and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabol...
2025-03-14 16:35
4092
Accropeutics Secured $12 Million in Series B Plus Financing
* Approximately $12 million additional financing led by Shenzhen Capital Group (SCGC), with participation from existing investor Morningside Ventures, and new investors Leader Venture Investment (SZTI) and Hefei Sci-Tec Venture Capital (HFST). * Cash runway extended into the second half of 20...
2025-03-14 16:23
2435
Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma
HONG KONG, March 14, 2025 /PRNewswire/ -- Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ("KLN"). Leveraging Kerry Pharma's extensive logistics (fourth-party logistics, 4PL) distribution capabilities, this collaborat...
2025-03-14 15:27
3361
Bowtie and Gleneagles Hospital Hong Kong Collaborate to Upgrade VHIS Rider to Include Histotripsy Treatment In "Bowtie & Gleneagles Hospital Wellness Package"
Swift inclusion of innovative liver tumor treatment technology, lowers barriers for Hongkongers to access advanced medical services HONG KONG, March 14, 2025 /PRNewswire/ -- Bowtie, Hong Kong's first virtual insurer[1], collaborates with Gleneagles Hospital Hong Kong (Gleneagles), Asia's first p...
2025-03-14 13:54
3454
VISTA Eye Specialist Enhances Cataract Surgery with Advanced Technology and Strategic Partnerships
PETALING JAYA, Malaysia, March 14, 2025 /PRNewswire/ -- Klinik Pakar Mata VISTA Eye Specialist (VISTA), awell-established name in eye care in Malaysia, continues to improve itscataract surgery services through collaborations with recognized ophthalmic technology providers such as Johnson & Johnso...
2025-03-14 08:00
2807
MATELASER Introduces X1 Performance: The Ultimate Portable High-Energy Laser Therapy System for Pain Management
MIAMI, March 13, 2025 /PRNewswire/ -- MATELASER, INC., a pioneering force in laser therapy technology, is proud to announce the launch of the X1 Performance, the portable high-energy laser therapy system, designed to meet the highest U.S. medical quality standards for pain management, sports rec...
2025-03-13 22:00
2380
Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation
CAMBRIDGE, Mass., March 13, 2025 /PRNewswire/ -- Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today that it has successfully secured a$110 million Series E financing led by a private equity fund of Value Partners ...
2025-03-13 21:00
3250
Amcor prices private offering of $2.2 billion of senior unsecured notes
ZURICH, March 13, 2025 /PRNewswire/ -- Amcor plc (NYSE:AMCR; ASX:AMC) ("Amcor") announced today that Amcor Flexibles North America, Inc. ("AFNA"), a wholly-owned subsidiary of Amcor, has priced a private offering (the "Offering") of guaranteed senior notes in an aggregate principal amount of$2.2 ...
2025-03-13 18:11
3953
IFPA Forum Americas 2025: "Towards More Equitable, Person-Centered Care for All People Living with Psoriatic Disease in the Americas"
On April 4, 2025, IFPA will host the IFPA Forum 2025 for the Americas in Bogotá, Colombia. This marks the third regional forum of its kind, following successful gatherings inEurope (2022) and Asia (2023). STOCKHOLM , March 13, 2025 /PRNewswire/ -- The IFPA Forum 2025 will unite stakeholders from...
2025-03-13 17:00
2705
KLN Selected by Teva as its Exclusive 4PL Service Provider in the Greater Bay Area
HONG KONG, March 13, 2025 /PRNewswire/ -- Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for fourth-party logistics (4PL) distribution services inHong Kong, M...
2025-03-13 16:30
2756
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025
SHANGHAI, March 13, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been honored with...
2025-03-13 13:54
2621
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
SHANGHAI, March 13, 2025 /PRNewswire/ -- BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA), to evaluate the combination of BioCity's BC3195 ...
2025-03-13 13:17
6931
Caliber Launches 4 Analytics and AI-driven Solutions to Revolutionize Pharma Manufacturing and Quality
PITTSBURGH, March 13, 2025 /PRNewswire/ -- Caliber
2025-03-13 09:00
2333
GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy
YONGIN, South Korea, March 12, 2025 /PRNewswire/ -- GC Cell (KRX:144510), under the leadership of CEOSungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5 CAR‑NK cell therapy. This "first patient dosing" marks a critical milestone in...
2025-03-13 07:30
2163
STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
* STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. * Approved for the same indications as the reference product, STEQEYMA will be priced with a wholesale acquisition cost (WAC) list price at an 85% discount to the current WAC list price of STELARA to help...
2025-03-13 07:30
2270
Telix Adds Lead-212 Isotope Production Capability
MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated a breakthrough generator technology for the production of lead-212 (212Pb) and successfully completed...
2025-03-13 06:48
3611
111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
SHANGHAI, March 12, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will par...
2025-03-12 19:00
2213
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
CASTRES, France, CAMBRIDGE, Massachusetts and BASEL, Switzerland, March 12, 2025 /PRNewswire/ -- Pierre Fabre Laboratories and RedRidge Bio ("RedRidge") today announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates against ...
2025-03-12 17:00
2293
Caliway's CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal
Advancing Scientific Recognition in Non-Surgical Fat Reduction * Caliway's CBL-514 Phase 2 study (CBL-0202) has been accepted for publication inAesthetic Surgery Journal (ASJ), the top-ranked journal in aesthetic medicine and plastic surgery. * Clinical data (ITT population) showed that over ...
2025-03-12 14:29
2140
Week's Top Stories
Most Reposted
Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum
[Picked up by 318 media titles]
2026-01-29 15:06
Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 309 media titles]
2026-01-27 13:00
Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
[Picked up by 294 media titles]
2026-01-27 18:00
Multi-Award Winning Phuket Marriott Resort & Spa, Merlin Beach: Voted Top 3 Best Family Resort
[Picked up by 283 media titles]
2026-01-30 08:00
True 1000Hz Powerhouse: PHILIPS EVNIA Unleashes the World's First 1000Hz Dual-Mode Gaming Monitor 27M2N5500XD
[Picked up by 282 media titles]
2026-01-29 18:03
